[1]Ishizawa T, Hasegawa K, Aoki T, et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma[J]. Gastroenterology, 2008,134(7):1908-1916.
[2]Shi Y, Wang XH, Zhang HH, et al. Quantitative analysis of real-time tissue elastography for evaluation of liver fibrosis[J]. Int J Clin Exp Med, 2014,7(4):1014-1021.
[3]Rahbari NN, Garden OJ, Padbury R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS)[J]. Surgery, 2011,149(5):713-724.
[4]胡彦, 徐超丽, 杨斌. 超声弹性成像定量参数对乳腺实性肿块的鉴别诊断分析[J]. 医学研究生学报, 2016,29(8):836-840.
[5]蔡石龙, 马芬芬, 陈烨, 等. 声触诊组织成像鉴别临床不易触诊乳腺小结节的应用价值[J]. 东南国防医药, 2017,19(2):167-170.
[6]European Association for Study of Liver. EASL Clinical Practice Guidelines: management of hepatitis C virus infection[J]. J Hepatol, 2014,60(1): 183-184.
[7]Wang J, Guo L, Shi X, et al. Real-time elastography with a novel quantitative technology for assessment of liver fibrosis in chronic hepatitis B[J]. Eur J Radiol, 2012,81(1):e31-36.
[8]Morikawa H, Fukuda K, Kobayashi S, et al. Real-time tissue elastography as a tool for the noninvasive assessment of liver stiffness in patients with chronic hepatitis C[J]. J Gastroenterol, 2011,46(3):350-358.
[9]Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1803 consecutive cases over the past decade[J]. Ann Surg, 2002,236(4):397-407.
[10]Lafaro K, Buettner S, Maqsood H, et al. Defining Post Hepatectomy Liver Insufficiency: Where do We stand?[J] J Gastrointest Surg, 2015,19(11):2079-2092.
[11]中华人民共和国卫生和计划生育委员会医政医管局. 原发性肝癌诊疗规范(2017年版)[J]. 临床肝胆病杂志, 2017,33(8):1419-1431.
[12]Cescon M, Colecchia A, Cucchetti A, et al. Value of transient elastography measured with FibroScan in predicting the outcome of hepatic resection for hepatocellular carcinoma[J]. Ann Surg, 2012,256(5):706-713.
[13]陈杨, 罗燕. 超声实时组织弹性成像评价乙型肝炎肝纤维化[J]. 华西医学, 2015,30(9):1671-1674.
[14]Qadan M, Garden OJ, Corvera CU, et al. Management of Postoperative Hepatic Failure[J]. J Am Coll Surg, 2016,222(2):195-208.
[15]倪俊声, 周伟平. 肝脏切除术后并发症及肝功能衰竭评价标准[J]. 中华普通外科杂志, 2014,29(7):566-568.
[16]刘慧敏, 毛青. 乙型肝炎肝衰竭的预警指标研究及预后效果评价[J]. 中西医结合肝病杂志, 2017,27(2):83-85.
[17]岳菊. 血清肿瘤标志物铁蛋白(FER)、甲胎蛋白(AFP)和总胆汁酸(TBA)联合检测对原发性肝癌早期诊断的临床价值[J]. 临床医药文献电子杂志, 2017,4(43):8358,8360.
[18]王守光, 马长林, 卢云, 等. 原发性肝癌肝切除术后肝功能衰竭的相关因素分析及防治[J]. 陕西医学杂志, 2007,36(6):691-693.
[19]邢时龙, 贾彬. 肝细胞癌预后影响因素的研究进展[J]. 中华临床医师杂志(电子版), 2015,9(24):140-144.
[20]Nishio T, Taura K, Koyama Y, et al. Prediction of posthepatectomy liver failure based on liver stiffness measurement in patients with hepatocellular carcinoma[J]. Surgery, 2016,159(2):399-408.
[21]刘朝辉, 杜振双, 林建泉, 等. 原发性肝癌肝切除术后发生肝功能衰竭的围术期影响因素分析[J]. 肝胆外科杂志, 2016,24(5):375-377.
[1]王金淳,杨 波,潘文琴,等.肝细胞肝癌MR DWI表现与病理学等级关系的分析[J].医学研究与战创伤救治(原医学研究生学报),2012,14(05):425.
WANG Jin-chun,YANG Bo,PAN Wen-qin,et al.Retrospective analysis of the relationship between manifestation of MR DWI and histopathologic grade of primary hepatic carcinoma[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2012,14(06):425.
[2]胡晓菡,田新宇,沈瀚.肝细胞肝癌患者血清中成纤维细胞生长因子19表达对早期诊断的意义[J].医学研究与战创伤救治(原医学研究生学报),2020,22(5):473.[doi:10.3969/j.issn.1672-271X.2020.05.005]
HU Xiao-han,TIAN Xin-yu,SHEN Han.The serological level of fibroblast growth factor-19 in hepatocarcinoma patients and its significance for early diagnosis of hepatocarcinoma[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2020,22(06):473.[doi:10.3969/j.issn.1672-271X.2020.05.005]